SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANRG -- Anergen -- new CEO big chance ?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Paul Jansen who wrote ()1/12/1998 6:04:00 PM
From: Russ B.  Read Replies (1) of 123
 
Working Capital? Has anyone heard comments from Anergen about raising more capital. The arthritis drug phase II results seem promising, but the company burned about $6 million of working capital in the first 9 months of 1997. They had $9.5 million of cash and ST investments as of 9/97, which means they've got maybe 1 1/2 years left. How are they going to get the funds needed to carry the drug to market?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext